Randomized crossover trial demonstrates enhanced microglobulin adsorption using PMMA filters in end-stage kidney disease, indicating improved removal of larger uremic toxins.
The prognosis of patients undergoing hemodialysis remains poorer than that of the general population, partly because of the insufficient removal of medium- and high-molecular-weight solutes using conventional filters. Polymethylmethacrylate (PMMA) filters may enhance solute removal via adsorption; however, their detailed properties remain unclear. This study investigated the adsorption and removal of β 2 -microglobulin (β2-MG) and α 1 -microglobulin (α1-MG) using PMMA filters in patients with end-stage kidney disease (ESKD). A randomized crossover study compared PMMA and polysulfone (PS) filters in 10 patients with ESKD. Blood-side clearance, adsorption clearance, and total adsorption of β2-MG and α1-MG were measured during hemodialysis. The adsorption of β2-MG by PMMA was greater than by PS (170.1 ± 84.7 mg vs. − 20.5 ± 34.7 mg, 15–240 min, p = 0.0001 ). The adsorption was higher with PMMA than with PS (248.3 ± 152.5 vs. − 17.7 ± 251.4 mg, p = 0.0033 ), and total α1-MG removal was also greater with PMMA than with PS (290.6 ± 153.4 vs. 31.9 ± 253.8 mg, p = 0.0032 ). Blood-side clearance of α1-MG did not differ significantly between the filters (15.5 ± 16.6 vs. 6.0 ± 12.1 mL/min at 60 min, p = 0.0909 ). PMMA filters showed superior adsorption of β2-MG and α1-MG compared with PS filters, suggesting an effective strategy for removing medium- and high-molecular-weight solutes through adsorption.
No takes yet. Share an insight, caveat, or question.
Miyauchi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: